This topic contains a solution. Click here to go to the answer

Author Question: During the double-blind, placebo-controlled food challenge, _____. a. only the care provider knows ... (Read 193 times)

tingc95

  • Hero Member
  • *****
  • Posts: 556
During the double-blind, placebo-controlled food challenge, _____.
 a. only the care provider knows whether a suspected offending food or a placebo is being tested
  b. only the patient knows whether a suspected offending food or a placebo is being tested
  c. neither the patient nor the care provider knows whether a suspected offending food or a placebo is being tested
  d. both the patient and the care provider know whether a suspected offending food or a placebo is being tested
  e. medical supervision is not needed

Question 2

The phytochemical _____ helps decrease chronic inflammation due to excess body fat, improves insulin utilization, and may decrease bone loss.
 a. quercetin
  b. proanthocyanidins
  c. lycopene
  d. beta-carotene
  e. lutein



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cuttiesgirl16

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

c

Answer to Question 2

a




tingc95

  • Member
  • Posts: 556
Reply 2 on: Aug 20, 2018
Gracias!


marict

  • Member
  • Posts: 304
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

A serious new warning has been established for pregnant women against taking ACE inhibitors during pregnancy. In the study, the risk of major birth defects in children whose mothers took ACE inhibitors during the first trimester was nearly three times higher than in children whose mothers didn't take ACE inhibitors. Physicians can prescribe alternative medications for pregnant women who have symptoms of high blood pressure.

Did you know?

Allergies play a major part in the health of children. The most prevalent childhood allergies are milk, egg, soy, wheat, peanuts, tree nuts, and seafood.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library